We're introducing a new look for GreyStone

Cardiogenetics

Talk to an expert >

Heart Disease accounts for 1 in 4 deaths in the U.S.

Every 60 seconds someone dies of a cardiovascular disease.

$30.7 billion is the yearly cost associated with heart failure in the U.S.

In the US, someone has a heart attack every 34 seconds.

Up to 50% of cardiovascular conditions have an identifiable hereditary cause.

Talk to an Expert

Cardiogenetics: The Clinical Edge You Need

Advances in genetic diagnostics are improving our understanding of a variety of hereditary cardiovascular conditions—including cardiomyopathies, arrhythmic disorders, vascular disorders, and lipid disorders such as familial hypercholesterolemia. Appropriate clinical management of cardiovascular disease depends upon a timely and accurate diagnosis.

As a specialty diagnostic laboratory renowned for excellence and expertise, GreyStone Labs develops industry-defining solutions designed to address the unique needs of healthcare professionals and their diverse patient populations.

Talk to an Expert

What Can GreyStone Do for You?

GreyStone Labs partners with healthcare providers to integrate genetic testing into patient care. We provide people—providers and patients—with the vital information they need to make clinically actionable decisions about individual healthcare challenges.

Arrhythmias:

  • Long QT Syndrome
  • Short QT Syndrome
  • Brugada Syndrome
  • Catecholaminergic Polymorphic Ventricular Tachycardia
  • Sick Sinus Syndrome
  • Wolff-Parkinson-White Syndrome

Cardiomyopathies:

  • Hypertrophic
  • Arrhythmogenic
  • Non-Compaction
  • Dilated
  • Restrictive
  • Infiltrative
  • Amyloid

Aortopathies:

  • Thoracic Aortic Aneurysms and Dissections
  • Loeys-Dietz and Marfan Syndromes

Lipidemias:

  • Familial Hypercholesterolemia
  • Sisosterolemia
  • Chylomicronemia

Greater insight
Greater impact

GreyStone’s vision is to make it possible for healthcare providers and their patients to benefit from genomics-driven, precision-based medicine.

Genetic testing can provide you and your patients with greater insight, improving the accuracy of your diagnoses and increasing the impact of your care.

With GreyStone Labs, you can count on the value of an integrated, industry-defining approach to patient-centered healthcare.

All major cardiology professional societies, including the American College of Cardiology, American Heart Association, Heart Rhythm Society, and Heart Failure Society of America, recommend genetic testing.

The Power of More: Improving Healthcare through Genetics

Genetic testing is impacting the way we pursue patient care, enabling healthcare providers like you to arrive at more accurate diagnoses, provide more individualized care, and more effectively treat your patients.

Why GreyStone?

GreyStone Labs is a state-of-the-art, specialty laboratory that provides a suite of advanced diagnostic services and support. Our commitment to excellence and innovation puts us in the unique position to provide the highest-quality, most cost-effective services on the market.

We leverage our expertise and passion for innovation to provide superior, precision-based testing with the most competitive turnaround time in the industry. Guaranteed.

Talk to an Expert